MTOR and ovarian carcinoma: The analysis of immunoblotting showed that the PI3K inhibitor LY294002 and mTOR inhibitor rapamycin significantly eliminated the upregulation of geminin protein stimulated with LPA in ovarian cancer cells, whereas DMSO had no effect (Figures 2I, J).